Larimar Therapeutics Inc (LRMR)
Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’sAtaxia
Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’sAtaxia
There are no comments here yet...